Jaysynth Orgochem Q1FY27: Board okays results, new auditor

Board clears Q1FY27 unaudited results

Jaysynth Orgochem Limited said its Board has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The update signals completion of the quarterly review process at the Board level. The company indicated that the results are unaudited, which is typical for first-quarter reporting. However, the press release context provided did not include the detailed financial numbers for the quarter ended June 30, 2026. That means investors will have to rely on the formal financial statements and filings for line-by-line performance. The announcement, nonetheless, is a standard governance step that enables the company to proceed with disclosures and compliance requirements.

Statutory auditor appointed for a five-year term

Alongside the quarterly approval, Jaysynth Orgochem appointed Chhogmal & Co. as its statutory auditors. The appointment is for five years, as stated in the provided context. Statutory auditor appointments matter for listed companies because the auditor is responsible for auditing annual financial statements and reviewing periodic results as required. A multi-year tenure can also reduce continuity risks in audit planning and reporting. The company’s update did not add further detail on the effective date or transition process in the text provided. Still, the core point is that the Board combined results approval with a key governance decision.

What was not disclosed in the Q1FY27 note

The text provided explicitly states that the specific financial figures for the quarter ended June 30, 2026 were not detailed in the press release. So, there is no official Q1FY27 revenue, profit, margin, or balance-sheet data to summarise directly from that release. Investors tracking quarterly momentum therefore need to refer to the company’s complete unaudited financial results document. This gap is important because headline approvals alone do not explain what moved earnings in the quarter. For readers, it also means that comparisons to earlier quarters must be based only on the figures that were separately provided in the broader dataset.

FY26 profitability and revenue base

For the financial year ended March 31, 2026, Jaysynth Orgochem reported a net profit of ₹147.48 crore. Revenue from operations for the same year stood at ₹2,553.70 crore. These FY26 numbers provide a baseline for understanding the scale of the company’s operations when assessing quarterly performance. Annual profit and revenue also help investors judge whether quarterly movements are meaningful relative to the full-year base. The company’s Q1FY27 approval comes after this reported FY26 outcome.

Quarterly snapshot provided: quarter ended Jun 25

A separate quarterly snapshot in the provided content lists figures for a quarter labelled “Jun 25”. In that table, Total Revenue is ₹59.01 crore versus ₹69.46 crore in “Mar 26”, with a QoQ change shown as -1.39% and a YoY change of 17.15% versus “Jun 24”. Net Income is shown at ₹1.72 crore for “Jun 25” compared with ₹5.66 crore for “Mar 26”, reflecting a QoQ change of -43.92% and a YoY change of -39.94% versus “Jun 24”. Net Income Before Taxes is shown at ₹2.53 crore for “Jun 25”, and Operating Income is shown at ₹3.02 crore. Selling, general and admin expenses total are listed at ₹5.78 crore, while depreciation/amortization is ₹0.69 crore. The same table shows diluted normalized EPS of ₹0.13 for “Jun 25”.

Another results summary in the dataset shows different Q1 numbers

The provided dataset also includes a narrative summary stating that standalone revenue increased by 15.88% to ₹5,777.17 crore, while profit after tax declined by 27.20% to ₹185.94 crore. For consolidated results, it states revenue from operations grew by 17.15% to ₹5,900.84 crore and consolidated PAT decreased by 39.94% to ₹171.80 crore. A supporting table in the dataset repeats these figures and also lists Basic EPS of ₹0.14 (standalone) and ₹0.13 (consolidated), with previous-year Basic EPS of ₹0.19 (standalone) and ₹0.21 (consolidated). These figures are presented in the text provided, though they differ sharply from the “Total Revenue ₹59.01 crore” snapshot shown elsewhere in the same dataset. Because the instruction is to use only what is explicitly present, both sets are reported here as they appear, without attempting to reconcile them.

Key figures and disclosures at a glance

Market references and company details cited

The content provided includes two separate references to the share price: one line states “current share price … ₹12” and another shows “Current Price ₹18.9”. These are presented as-is because they appear in the dataset, but they are not tied to a timestamp in the text provided. The dataset also provides the registered office address: 301 Sumer Kendra, Pandurang Budhkar Marg, Worli, Mumbai, Maharashtra 400018, along with the phone number 91-22-30423048. These details help investors verify company identification across filings, exchange disclosures, and corporate communications.

Why the update matters for investors

Two items typically draw investor attention in such disclosures: governance actions and the availability of current-period financial performance. The auditor appointment for five years is a governance event that can influence perceptions of reporting continuity and audit oversight. The Board’s approval of Q1FY27 unaudited results indicates that the internal close process and Board review have been completed. But the absence of Q1FY27 numbers in the press release text provided limits immediate analysis of quarter-on-quarter performance. Investors focused on earnings will likely wait for the full unaudited financial statements to understand revenue mix, cost trends, and profitability drivers.

Conclusion

Jaysynth Orgochem’s Board has approved unaudited standalone and consolidated results for the quarter ended June 30, 2026 and appointed Chhogmal & Co. as statutory auditors for a five-year term. The press release context provided does not include Q1FY27 figures, while other figures in the dataset show multiple quarterly snapshots that should be cross-checked with the company’s formal filings. The next key step for investors is to track the detailed unaudited financial statements associated with the quarter ended June 30, 2026 and any subsequent exchange disclosures.